CORC

在结果中检索

CORC

浏览/检索结果: 共14条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303. 期刊论文
Thoracic cancer, 2019, 卷号: 10, 页码: 551-556
作者:  Si Xiaoyan;  Zhang Li;  Wang Hanping;  Zhang Xiaotong;  Wang Mengzhao
收藏  |  浏览/下载：34/0  |  提交时间：2019/11/19
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303 期刊论文
THORACIC CANCER, 2019, 卷号: 10, 期号: 3, 页码: 551-556
作者:  Si, Xiaoyan;  Zhang, Li;  Wang, Hanping;  Zhang, Xiaotong;  Wang, Mengzhao
收藏  |  浏览/下载：25/0  |  提交时间：2019/12/11
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303 期刊论文
2019, 卷号: 10, 期号: 3, 页码: 551-556
作者:  Si, Xiaoyan;  Zhang, Li;  Wang, Hanping;  Zhang, Xiaotong;  Wang, Mengzhao
收藏  |  浏览/下载：13/0  |  提交时间：2020/01/03
SOMCL-085, a novel multi-targeted FGFR inhibitor, displays potent anticancer activity in FGFR-addicted human cancer models 期刊论文
ACTA PHARMACOLOGICA SINICA, 2018, 卷号: 39, 期号: 2, 页码: 243-250
作者:  Jiang, Xi-fei;  Dai, Yang;  Peng, Xia;  Shen, Yan-yan;  Su, Yi
收藏  |  浏览/下载：53/0  |  提交时间：2019/01/08
somcl085anovelmultitargetedfgfrinhibitordisplayspotentanticanceractivityinfgfraddictedhumancancermodels 期刊论文
actapharmacologicasinica, 2018, 卷号: 39, 期号: 2, 页码: 243
作者:  Jiang Xifei;  Dai Yang;  Peng Xia;  Shen Yanyan;  Su Yi
收藏  |  浏览/下载：3/0  |  提交时间：2020/07/01
Discovery of novel Ponatinib analogues for reducing KDR activity as potent FGFRs inhibitors 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 126, 页码: 122-132
作者:  Liu, Yang;  Peng, Xia;  Guan, Xiaocong;  Lu, Dong;  Xi, Yong
收藏  |  浏览/下载：42/0  |  提交时间：2019/01/08
Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 卷号: 9
作者:  Sun, Yongkun;  Niu, Wei;  Du, Feng;  Du, Chunxia;  Li, Shuting
收藏  |  浏览/下载：35/0  |  提交时间：2019/01/08
Expanding the structural diversity of diarylureas as multi-target tyrosine kinase inhibitors 期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 卷号: 24, 期号: [db:dc_citation_issue], 页码: 750-758
作者:  Shan, Yuanyuan;  Wang, Chen;  Zhang, Lin;  Wang, Jinfeng;  Wang, Maoyi
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/02
Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors 期刊论文
2016, 卷号: 9, 期号: 1, 页码: 105
作者:  Sun, Yongkun;  Niu, Wei;  Du, Feng;  Du, Chunxia;  Li, Shuting
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04
Anti-Angiogenic Properties of BDDPM, a Bromophenol from Marine Red Alga Rhodomela confervoides, with Multi Receptor Tyrosine Kinase Inhibition Effects 期刊论文
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 卷号: 16, 期号: 6, 页码: 13548-13560
作者:  Wang, Shuaiyu;  Wang, Li-Jun;  Jiang, Bo;  Wu, Ning;  Li, Xiangqian
收藏  |  浏览/下载：28/0  |  提交时间：2015/12/07

©版权所有 ©2017 CSpace - Powered by CSpace